[Use of the Nd:YAG laser in otorhinolaryngology].
The Nd:YAG laser is suitable for the treatment of various otorhinolaryngological clinical disorders. These include the palliative reduction of tumor size in sites with difficult access, treatment of hemangiomas and reduction of hyperplastic turbinates. Within certain limits, other indications are treatment of recurrent epistaxis and recurrent polyposis. Palliative reduction of malignancies in the nasopharynx, esophagus, and bronchial system (laser power density: 1500-8000 W/cm2) must sometimes be carried out in several sessions in order to avoid complications due to the laser (i.e., perforation of the bronchial or esophageal wall, lesions of adjacent vessels or nerves). Nd:YAG laser treatment of hemangiomas (500-3000 W/cm2) can lead to excellent results. To avoid excessive thermal lesions, vascular tissue is cooled with ice cubes or with an ice-cold Ringer's solution. The laser process is continued until the onset of tissue blanching. Carbonizations of the tissue are to be avoided. In Nd:YAG laser therapy of hyperplastic lower nasal conchae (approx. 1000 W/cm2), results are based on submucous scarring in which the covering epithelium is maintained. The objective of Nd:YAG laser treatment of recurrent epistaxis in patients with Osler's disease (500 W/cm2) is to reduce the incidence of hemorrhage. Use of the laser in recurrent polyposis is best confined to patients who refuse conventional surgical revision operations. Laser light (500-3500 W/cm2) should only be applied for a short period of time (0.5 s) to avoid creating a rarefying osteitis.
Werner
J A
JA
Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie, Universität Kiel.
Rudert
H
H
D000402:Airway Obstruction / Q000601:surgery; D019723:Endoscopes; D006801:Humans; D053685:Laser Therapy / Q000295:instrumentation*; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D010039:Otorhinolaryngologic Neoplasms / Q000601:surgery*
Der Einsatz des Nd:YAG-Lasers in der Hals-, Nasen-, Ohrenheilkunde.